Climb Bio Stock Analysis
| CLYM Stock | 5.63 0.01 0.18% |
Climb Bio's financial leverage is the degree to which the firm utilizes its fixed-income securities and uses equity to finance projects. Companies with high leverage are usually considered to be at financial risk. Climb Bio's financial risk is the risk to Climb Bio stockholders that is caused by an increase in debt. In other words, with a high degree of financial leverage come high-interest payments, which usually reduce Earnings Per Share (EPS).
Given that Climb Bio's debt-to-equity ratio measures a Company's obligations relative to the value of its net assets, it is usually used by traders to estimate the extent to which Climb Bio is acquiring new debt as a mechanism of leveraging its assets. A high debt-to-equity ratio is generally associated with increased risk, implying that it has been aggressive in financing its growth with debt. Another way to look at debt-to-equity ratios is to compare the overall debt load of Climb Bio to its assets or equity, showing how much of the company assets belong to shareholders vs. creditors. If shareholders own more assets, Climb Bio is said to be less leveraged. If creditors hold a majority of Climb Bio's assets, the Company is said to be highly leveraged.
Climb Bio is undervalued with Real Value of 6.81 and Hype Value of 5.12. The main objective of Climb Bio stock analysis is to determine its intrinsic value, which is an estimate of what Climb Bio is worth, separate from its market price. There are two main types of Climb Bio's stock analysis: fundamental analysis and technical analysis.
The Climb Bio stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Climb Bio is usually not traded on Labour Day, Thanksgiving Day, Christmas Day, New Year 's Day, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday, Memorial Day, Juneteenth Holiday, Independence Day ( substitute day ), Independence Day. Climb Stock trading window is adjusted to America/New York timezone.
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Climb Bio. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment. Climb Stock Analysis Notes
About 54.0% of the company shares are held by institutions such as insurance companies. The book value of Climb Bio was currently reported as 2.6. The company recorded a loss per share of 0.59. Climb Bio had not issued any dividends in recent years. For more info on Climb Bio please contact BAO BCh at 866 857 2596 or go to https://climbbio.com.Climb Bio Investment Alerts
| Climb Bio is way too risky over 90 days horizon | |
| Climb Bio appears to be risky and price may revert if volatility continues | |
| Net Loss for the year was (73.9 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Climb Bio generates negative cash flow from operations | |
| Climb Bio has a frail financial position based on the latest SEC disclosures |
Climb Market Capitalization
The company currently falls under 'Small-Cap' category with a current market capitalization of 375.01 M.Technical Drivers
As of the 20th of February, Climb Bio shows the Risk Adjusted Performance of 0.2099, mean deviation of 6.71, and Downside Deviation of 5.99. Climb Bio technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Please confirm Climb Bio information ratio, as well as the relationship between the potential upside and kurtosis to decide if Climb Bio is priced correctly, providing market reflects its regular price of 5.63 per share. Given that Climb Bio has jensen alpha of 2.18, we suggest you to validate Climb Bio's prevailing market performance to make sure the company can sustain itself at a future point.Climb Bio Price Movement Analysis
The output start index for this execution was nine with a total number of output elements of fifty-two. The Simple Moving Average indicator is calculated by adding the closing price of Climb Bio for a given number of time periods and then dividing this total by the number of time periods. It is used to smooth out Climb Bio short-term fluctuations and highlight longer-term trends or cycles.
Climb Bio Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Climb Bio insiders, such as employees or executives, is commonly permitted as long as it does not rely on Climb Bio's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Climb Bio insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Climb Bio Outstanding Bonds
Climb Bio issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Climb Bio uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Climb bonds can be classified according to their maturity, which is the date when Climb Bio has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| Valero Energy Partners Corp BondUS91914JAA07 | View |
Climb Bio Predictive Daily Indicators
Climb Bio intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Climb Bio stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Climb Bio Forecast Models
Climb Bio's time-series forecasting models are one of many Climb Bio's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Climb Bio's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.Climb Bio Bond Ratings
Climb Bio financial ratings play a critical role in determining how much Climb Bio have to pay to access credit markets, i.e., the amount of interest on their issued debt. The threshold between investment-grade and speculative-grade ratings has important market implications for Climb Bio's borrowing costs.| Piotroski F Score | 2 | Frail | View |
| Beneish M Score | (7.61) | Unlikely Manipulator | View |
Climb Bio Assets Financed by Debt
Typically, companies with high debt-to-asset ratios are said to be highly leveraged. The higher the ratio, the greater risk will be associated with the Climb Bio's operation. In addition, a high debt-to-assets ratio may indicate a low borrowing capacity of Climb Bio, which in turn will lower the firm's financial flexibility.Climb Bio Corporate Bonds Issued
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Climb Bio to your portfolios without increasing risk or reducing expected return.Did you try this?
Run USA ETFs Now
USA ETFsFind actively traded Exchange Traded Funds (ETF) in USA |
| All Next | Launch Module |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Climb Bio. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment. To learn how to invest in Climb Stock, please use our How to Invest in Climb Bio guide.You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.
Will Biotechnology sector continue expanding? Could Climb diversify its offerings? Factors like these will boost the valuation of Climb Bio. Projected growth potential of Climb fundamentally drives upward valuation adjustments. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Climb Bio data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
The market value of Climb Bio is measured differently than its book value, which is the value of Climb that is recorded on the company's balance sheet. Investors also form their own opinion of Climb Bio's value that differs from its market value or its book value, called intrinsic value, which is Climb Bio's true underlying value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Because Climb Bio's market value can be influenced by many factors that don't directly affect Climb Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
It's important to distinguish between Climb Bio's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Climb Bio should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Meanwhile, Climb Bio's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.